Home › Smoldering Multiple Myeloma
Pag-aaral pangklinika para sa Smoldering Multiple Myeloma na nagre-recruit sa U.S.
20 pag-aaral para sa Smoldering Multiple Myeloma ang nagre-recruit ng mga kalahok sa mga site sa buong Estados Unidos.
Mga lungsod na may pinakamaraming pag-aaral
- New York City, NY6 pag-aaral
- Boston, MA6 pag-aaral
- Atlanta, GA5 pag-aaral
- Edison, NJ3 pag-aaral
- Houston, TX3 pag-aaral
- Columbus, OH3 pag-aaral
- Durham, NC3 pag-aaral
- Denver, CO3 pag-aaral
- Salt Lake City, UT3 pag-aaral
Ayos sa estado
- Colorado3 pag-aaral
- Florida4 pag-aaral
- Georgia5 pag-aaral
- Massachusetts6 pag-aaral
- Michigan4 pag-aaral
- New Jersey3 pag-aaral
- New York8 pag-aaral
- North Carolina4 pag-aaral
- Ohio3 pag-aaral
- Texas4 pag-aaral
- Utah3 pag-aaral
Mga pag-aaral na kamakailan lamang in-update
Opisyal na teksto ng pag-aaral (English)
A Study to Compare Linvoseltamab and Daratumumab Treatment in High-Risk Smoldering Multiple Myeloma (HR-SMM)
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Set 25, 2026 · NCT07393282A Study of JNJ-79635322 in Combination With Daratumumab With or Without Lenalidomide for Multiple Myeloma, Newly Diagnosed AL Amyloidosis, and High-risk Smoldering Multiple Myeloma or JNJ-79635322 in Combination With Pomalidomide for Multiple Myeloma
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Set 25, 2026 · NCT06768489Lenalidomide, and Dexamethasone With or Without Daratumumab in Treating Patients With High-Risk Smoldering Myeloma
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Ago 19, 2026 · NCT03937635Immuno-PRISM (PRecision Intervention Smoldering Myeloma)
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Hul 16, 2026 · NCT05469893CHAAMP (CHArlotte Advocate MGUS Project) Internal Pilot Study
Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo
Edad 30 pataas · Lahat ng kasarian · Na-update Hul 13, 2026 · NCT06644625A Proof-of-Concept Study to Learn Whether Linvoseltamab Can Eliminate Abnormal Plasma Cells That May Lead to Multiple Myeloma in Adult Patients With High-Risk Monoclonal Gammopathy of Undetermined Significance or Non-High-Risk Smoldering Multiple Myeloma
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Hul 8, 2026 · NCT06140524Iberdomide Alone or in Combination With Dexamethasone for the Treatment of Intermediate- or High-Risk Smoldering Multiple Myeloma
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Hun 1, 2026 · NCT04776395Study of MGUS, Smoldering Myeloma, Early MDS and CLL to Assess Molecular Events of Progression and Clinical Outcome
Nagre-recruitObservasyonal na pag-aaral
Edad 18 pataas · Lahat ng kasarian · Na-update May 7, 2026 · NCT02269592FAST-M: Prolonged Overnight Fasting and Mediterranean Dietary Intervention for Patients With Multiple Myeloma or Its Precursor Disease
Nagre-recruit
Edad 18 pataas · Lahat ng kasarian · Na-update May 1, 2026 · NCT07446777Observational Prospective Research Study In Monoclonal Gammopathies leadINg to Myeloma
Nagre-recruitObservasyonal na pag-aaral
Edad 18 pataas · Lahat ng kasarian · Na-update Abr 21, 2026 · NCT02726750A Study Comparing a Plant-Based Diet With Supplements and Placebo in People With Monoclonal Gammopathy of Undetermined Significance (MGUS) or Smoldering Multiple Myeloma (SMM)
Nagre-recruit
Edad 18 pataas · Lahat ng kasarian · Na-update Abr 16, 2026 · NCT05640843Quality of Life in Patients With Asymptomatic Monoclonal Gammopathies
Nagre-recruitObservasyonal na pag-aaral
Edad 18 pataas · Lahat ng kasarian · Na-update Abr 15, 2026 · NCT05136807Two Biologically and Clinically Distinct Entities: Progressive Versus Stable Multiple Myeloma (MM) Precursor Conditions
Nagre-recruitObservasyonal na pag-aaral
Edad 18 pataas · Lahat ng kasarian · Na-update Abr 9, 2026 · NCT05361694Smoldering Myeloma High-Risk Patient Observation and Longitudinal Insight Trial
Nagre-recruitObservasyonal na pag-aaral
Edad 18 pataas · Lahat ng kasarian · Na-update Peb 17, 2026 · NCT06212323Non-chemotherapeutic Interventions for the Improvement of Quality of Life and Immune Function in Patients With Multiple Myeloma
Nagre-recruit
Edad 18 pataas · Lahat ng kasarian · Na-update Dis 1, 2025 · NCT05312255Registry for Adults With Plasma Cell Disorders (PCD's)
Nagre-recruitObservasyonal na pag-aaral
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 20, 2025 · NCT03717844A Study of a Plant-Based Diet and Dietary Supplements in People With Smoldering Multiple Myeloma (SMM) or Monoclonal Gammopathy of Undetermined Significance (MGUS)
Nagre-recruit
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 13, 2025 · NCT06055894The Indiana Myeloma Registry
Nagre-recruitObservasyonal na pag-aaral
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 10, 2025 · NCT03616483Screening for AL Amyloidosis in Smoldering Multiple Myeloma
Nagre-recruitObservasyonal na pag-aaral
Edad 40 pataas · Lahat ng kasarian · Na-update Ago 6, 2025 · NCT06365060Selinexor for the Treatment of Intermediate and High-Risk Smoldering Multiple Myeloma
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Peb 10, 2025 · NCT05597345Mula sa ClinicalTrials.gov, na-kuha noong Set 30, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.